Jay M Phd Short insider trades: BioAtla (BCAB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jay reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 20, 2023 | BCAB | ↑ Buy | 50,000 | $2.14 | $107K | Direct | Dec 20, 2023 (0d) |
| Mar 29, 2023 | BCAB | ↑ Buy | 40,800 | $2.47 | $101K | Direct | Mar 30, 2023 (1d) |
| Aug 12, 2022 | BCAB | ↑ Buy | 26,350 | $7.84 | $207K | Direct | Aug 15, 2022 (3d) |
| Jun 22, 2022 | BCAB | ↑ Buy | 69,390 | $2.86 | $198K | Direct | Jun 23, 2022 (1d) |
| Dec 2, 2021 | BCAB | ↓ Sell | 47,622 | $23.48 | $1.1M | Direct | Dec 7, 2021 (5d) |
| Nov 29, 2021 | BCAB | ↓ Sell | 15,435 | $23.89 | $369K | Direct | Dec 6, 2021 (7d) |
| Nov 24, 2021 | BCAB | ↓ Sell | 57,640 | $25.26 | $1.5M | Direct | Nov 30, 2021 (6d) |
| Aug 24, 2021 | BCAB | ↓ Sell | 4,533 | $41.60 | $189K | By Spouse | Aug 26, 2021 (2d) |
| Jun 21, 2021 | BCAB | ↓ Sell | 74,269 | $39.16 | $2.9M | By Spouse | Jun 22, 2021 (1d) |
| Jun 16, 2021 | BCAB | ↓ Sell | 146,137 | $40.06 | $5.9M | By Spouse | Jun 16, 2021 (0d) |
| Oct 1, 2014 | SNMX | ↓ Sell | 7,500 | $8.16 | $61K | Direct | Oct 3, 2014 (2d) |
| Apr 1, 2014 | SNMX | ↓ Sell | 11,590 | $10.66 | $124K | Direct | Apr 2, 2014 (1d) |
| Jan 14, 2014 | SNMX | ↓ Sell | 4,090 | $6.50 | $27K | Direct | Jan 16, 2014 (2d) |
| May 1, 2008 | IVGN | ↓ Sell | 2,500 | $94.63 | $237K | Direct | May 5, 2008 (4d) |
| Feb 8, 2008 | IVGN | ↓ Sell | 13,800 | $88.12 | $1.2M | Direct | Feb 12, 2008 (4d) |
| Nov 1, 2007 | IVGN | ↓ Sell | 3,500 | $89.29 | $313K | Direct | Nov 5, 2007 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jay M Phd Short's insider trades
Jay M Phd Short is Chief Executive Officer at BioAtla (BCAB). Since Nov 1, 2007, Jay has reported 4 open-market purchases worth $613K and 12 sales worth $13.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (29 filings), grants and awards (22 filings), option exercises (8 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.